Skip to contentC
Chemed Corp
C
CHEChemed Corp Q1 2014 · 10-Q
Revenue$358.30M$358.30M−2.3% vs Q1 2013 Net Income$20.57M$20.57M−7.6% vs Q1 2013 EPS Diluted$1.12$1.12−4.3% vs Q1 2013 Operating Income$36,652,000−5.7% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
Free Cash Flowderived-$19,977,000N/M Margins · derivedOperating margin10.2%−0.4 pt vs Q1 2013
Net margin5.7%−0.3 pt vs Q1 2013
ended Mar 31, 2014 · filed May 2, 2014 · 32 d after period end